Quarterly report · Q3
4884.TEDINET S100RPCV
Period2022-10-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥52m | 2022-10-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥392m | 2021-10-01 → 2022-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥112m | 2021-10-01 → 2022-06-30 | Standalone | Net sales |
| Operating income | −¥620m | 2022-10-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | −¥383m | 2021-10-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | −¥578m | 2022-10-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥330m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥306m | 2021-10-01 → 2022-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥578m | 2022-10-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥306m | 2021-10-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | −¥579m | 2022-10-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | −¥332m | 2021-10-01 → 2022-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥307m | 2021-10-01 → 2022-06-30 | Standalone | Profit loss |
| Total assets | ¥2.8bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥3.2bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥3.0bn | at 2022-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥615m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥420m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥2.2bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥2.8bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥2.7bn | at 2022-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2022-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-107.45 | 2022-10-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-48.86 | 2023-04-01 → 2023-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-68.33 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.02 | 2021-10-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.55 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.0% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.8% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.9% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 5,390,700 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,380,700 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,196,400 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 245
| Item | Context | Value | Unit |
|---|---|---|---|
| Ordinary income | CurrentYTDDuration_NonConsolidatedMember | -577513000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | -305721000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | -577513000 | JPY |
| Income taxes current | Prior1YTDDuration_NonConsolidatedMember | 1117000 | JPY |
| Income taxes current | CurrentYTDDuration_NonConsolidatedMember | 1118000 | JPY |
| Income taxes | Prior1YTDDuration_NonConsolidatedMember | 1117000 | JPY |
| Income taxes | CurrentYTDDuration_NonConsolidatedMember | 1118000 | JPY |
| Profit loss | Prior1YTDDuration_NonConsolidatedMember | -306838000 | JPY |
| Profit loss | CurrentYTDDuration_NonConsolidatedMember | -578631000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第22期第３四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)クリングルファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Ｋｒｉｎｇｌｅ Ｐｈａｒｍａ， Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 安達 喜一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪府茨木市彩都あさぎ七丁目７番15号彩都バイオインキュベータ207 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)072-641-8739（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 村上 浩一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪府茨木市彩都あさぎ七丁目７番15号彩都バイオインキュベータ207 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)072-641-8739（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 村上 浩一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E36129 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48840 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)クリングルファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Kringle Pharma, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-10-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2023-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2021-10-01 | |
| Comparative period end date | FilingDateInstant | 2022-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |